Proactive Investors - Run By Investors For Investors

WideCells granted Innovate UK Knowledge Transfer Partnership for stem cell technology

The healthcare services company said as part of a three-year research project, Innovate UK will provide £156,000 worth of funding towards a total project cost of £234,000
cells
Following the research project, WideCells hope to have induced pluripotent stem cell to a point of commercialisation

WideCells Group PLC (LON:WDC) has announced that its 100%-owned stem cell storage and research division WideCells Ltd has been granted a government-backed Innovate UK Knowledge Transfer Partnership with Manchester Metropolitan University to undertake research on a new form of stem cell technology.

The healthcare services company said as part of this three-year research project, Innovate UK will provide £156,000 worth of funding towards a total project cost of £234,000.

WATCH: WideCells gets UK grant for pioneering skin-based stem cell technology

The new technology allows specialised adult cells such as skin cells to be genetically reprogrammed to assume a stem cell-like state and accordingly be used in stem cell treatment and in the study of disease.  

Following the research project, WideCells hopes to have these advanced induced pluripotent stem cells (iPSCs) to a point of commercialisation so that the technology can be included in the group’s end-to-end stem cell service offering.

Innovate UK, a government-backed public body that is committed to driving growth by working with companies to de-risk, enable and support innovation, will provide £52,000 per annum in funding for the three-year project and WideCells Group will provide £26,000 per annum.

Joao Andrade, CEO of WideCells, said: “By supporting the continued development of the industry, we help to ensure that our end-to-end stem cell service, which includes our unique stem cell insurance product, Cellplan, remains relevant to the market.”

View full WDC profile View Profile

WideCells Group Plc Timeline

Big Picture
April 18 2019

Related Articles

An illustration of Ozop's BLIF technique
March 30 2019
A key area of focus for the West Palm Beach, Florida, company is development of balloon lumbar interbody fusion (BLIF) technology
man pointing to brain
April 25 2019
Brain Scientific’s EEG technology is far cheaper and less bulky than a traditional EEG system, but provides EEG tracings of the same quality
woman touching her skin
May 21 2019
Here we take a closer look at Integumen PLC (LON:SKIN), which has developed and digitised an artificial skin

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use